Skip to main content
OpenTrials

Clinical trial condition

Prurigo Nodularis

Explore clinical trials studying Prurigo Nodularis. Study availability and eligibility vary by location and protocol.

35 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Prurigo Nodularis trial results

Completed

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

NCT05764161

Conditions
Dermatitis, Prurigo, Prurigo Nodularis, +2 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • Northwest Arkansas Clinical Trials Center Arkansas City, Arkansas, United States
  • Dermatology Research Associates Los Angeles, California, United States
  • Clinical Science Institute Clinical Research Specialists Inc Santa Monica, California, United States
View all 76 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

NCT06213831

Conditions
Prurigo Nodularis
Locations
  • Saguaro Dermatology Phoenix, Arizona, United States
  • Affiliated Dermatology Scottsdale, Arizona, United States
  • First Oc Dermatology Fountain Valley, California, United States
  • Amicis Research Center Valencia Northridge, California, United States
View all 20 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

NCT05061693

Conditions
Prurigo Nodularis
Locations
  • Investigative Site US010 Phoenix, Arizona, United States
  • Investigative Site US024 Phoenix, Arizona, United States
  • Investigative Site US001 Fountain Valley, California, United States
  • Investigative Site US014 Sacramento, California, United States
View all 49 locations
View Trial Details
Completed

Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis

NCT02174419

Conditions
Nodularis Prurigo, Pathological Conditions, Signs and Symptoms, Prurigo, +6 more
Locations
  • Case Western Reserve University Cleveland, Ohio, United States
  • Temple University Hospital Philadelphia, Pennsylvania, United States
  • University of Münster Münster, Germany
  • Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wroclawiu Wroclaw, Lower Silesian Voivodeship, Poland
View Trial Details
Completed

A Study to Evaluate the Durability of Response and Safety of Nemolizumab for 24 Weeks in Participants With Prurigo Nodularis

NCT05052983

Conditions
Prurigo Nodularis
Locations
  • Galderma Investigational Site 8521 Saint Joseph, Missouri, United States
  • Galderma Investigational Site 5471 Graz, Austria
  • Galderma Investigational Site 6158 Vienna, Austria
  • Galderma Investigational Site 5104 Brest, France
View all 14 locations
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501679

Conditions
Dermatitis, Neurodermatitis, Pathological Conditions, Signs and Symptoms, +8 more
Locations
  • Galderma Investigational Site Fountain Valley, California, United States
  • Galderma Investigational Site San Diego, California, United States
  • Galderma Investigational Site Washington D.C., District of Columbia, United States
  • Galderma Investigational Site Aventura, Florida, United States
View all 74 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501666

Conditions
Dermatitis, Neurodermatitis, Pathological Conditions, Signs and Symptoms, +8 more
Locations
  • Galderma Investigational Site Birmingham, Alabama, United States
  • Galderma Investigational Site Birmingham, Alabama, United States
  • Galderma Investigational Site Los Angeles, California, United States
  • Galderma Investigational Site Sacramento, California, United States
View all 100 locations
View Trial Details

Related conditions